Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Methylene Blue Bladder Instillation Versus No Intervention on Urinary Tract Injuries During Cesarean Hysterectomy for Placenta Accreta Spectrum: A Prospective Cohort Study

NCT07129135 is registered in ClinicalTrials.gov with Usama Ahmed Elsaeed Salem, MD as lead sponsor.

NCT NCT07129135
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07129135 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Methylene Blue Bladder Instillation Versus No Intervention on Urinary Tract Injuries During Cesarean Hysterectomy for Placenta Accreta Spectrum: A Prospective Cohort Study
Lead sponsor
Usama Ahmed Elsaeed Salem, MD
Phase
Not applicable
Overall status
Completed
Start date
January 22, 2023
Completion date
August 25, 2024
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

abnormal placentation, bladder injury, cesarean hysterectomy, placenta accreta spectrum, urinary tract injury